AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2016
Sep 21, 2016
34519_dirs_2016-09-21_2c4df0ff-df6f-4da5-bd86-2ff2e2a23c94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2016-09-19
Reporting Person: Cunningham David (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-19 | Common Stock, par value $0.10 per share | D | 7334.0000 | $7.8300 | Disposed | 2070.0000 | Direct |
| 2016-09-19 | Common Stock, par value $0.10 per share | M | 10000.0000 | $5.7500 | Acquired | 12070.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-19 | Non-qualified stock options (right to buy) | $5.7500 | M | 10000.0000 | Disposed | 2016-10-12 | Common Stock (10000.0000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23